Digital Health Startups
8,140 companies tagged Digital Health, with their investors and founders.
PromptWell provides an AI-native engagement platform designed for healthcare organizations and health plans to personalize member communications and guide them toward appropriate care services. The platform combines automated outreach, interactive workflows, and behavioral analytics to increase member engagement, reduce costs, and improve health outcomes.
2 investors
Reve is an AI revenue cycle management platform for hospitals and healthcare providers that validates claims before submission, audits payments, and manages denials to reduce denied and underpaid insurance claims. Built by former health insurance system designers, it covers the claim lifecycle from pre-surgery authorization checks through post-payment audit.
2 investors
ProofPilot is a sponsor-configured clinical trial platform covering the study lifecycle from enrollment forecasting through patient engagement, with tools for recruitment, site training, and participant retention. It serves clinical operations teams at biotechs and large pharma companies, offering a white-labeled, end-to-end alternative to piecing together multiple clinical trial vendors.
2 investors
Prospection turns longitudinal patient and real-world claims data into analytics that map the complete patient journey and predict likely next steps, using a proprietary transformer-based AI architecture. It serves pharmaceutical companies, supporting commercial and clinical decision-making across the drug lifecycle and more than 90 indications.
2 investors
Prosper Health is a telehealth platform providing psychological assessment and therapy services, with a focus on supporting neurodivergent and autistic adults. The platform connects clients with licensed psychologists, clinical social workers, and licensed therapists across multiple states who specialize in neurodiversity-affirming care.
2 investors
Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones. Its work targets patients affected by protein misfolding disorders.
2 investors
Protego Health provides AI-powered software that prevents insurance claim denials and automates appeals for healthcare organizations. The platform integrates into existing EHR systems to flag denial risks at the point of order, clinical note, and claim creation, and generates payer-specific appeals when denials occur.
2 investors
ProviderTrust provides automated exclusion list monitoring to healthcare organizations to identify excluded individuals and entities from federal and state databases. The solution continuously screens employees, physicians, and vendors against multiple government exclusion lists to prevent fraud, waste, and abuse in healthcare operations.
2 investors
Psych Hub is a clinical skill development platform for behavioral health, offering evidence-based, trauma-informed education, portable credentials, and applied-skill practice for mental health clinicians. It works with payers, provider organizations, and professional associations to define and certify a national quality standard for behavioral health care.
2 investors
Psilocybin biosynthesis platform that produces psychoactive molecular entities using yeast-based technology for pharmaceutical research and drug development.
2 investors
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.
2 investors
QRAGO is a transportation management platform that handles order processing, vehicle planning, routing, driver dispatch, and invoicing for medical facilities and logistics operations.
2 investors
Quadlytics develops medical devices and software, provides healthcare services, and offers consulting on data analysis for the healthcare industry. The company is based in Japan with offices in Kyoto, Kobe, and Melbourne.
2 investors
Quadrant Eye develops at-home diagnostic technology to conduct comprehensive eye examinations. The platform aims to increase access to eye care services and help prevent avoidable vision loss.
2 investors
Qualifacts provides electronic health record (EHR) and practice management software for behavioral health, substance use disorder, and human services providers in the U.S. It offers three platforms—Credible, CareLogic, and InSync—supporting clinical documentation, scheduling, ePrescribing, billing, analytics, and reporting for organizations ranging from small practices to large enterprise agencies.
2 investors
QualisureDx develops diagnostic tests using machine-learning and molecular analysis to identify unique cancer properties and guide personalized treatment decisions for oncologists. The company serves cancer care teams seeking to match patients with appropriate therapies that maximize efficacy while minimizing toxicity.
2 investors
Quantum Health provides healthcare navigation and care coordination for employees and their families, engaging members early in a care journey and guiding them to cost-effective in-network care. It serves employers as a benefits partner, aiming to improve member experiences while reducing claims costs.
2 investors
Quolabs is developing AI-based eldercare solutions aimed at making long-term care for seniors more affordable and accessible. It targets aging populations and their families in the United States, operating in the digital health and eldercare space.
2 investors
RADiCAIT develops Insilico PET, an AI-powered technology that transforms routine CT scans into functional disease activity maps without requiring radioactive tracers or additional hardware, enabling faster and more accessible diagnostic imaging at scale.
2 investors
Radley is an AI-native radiology group that reads imaging studies for hospitals and imaging centers, using AI to draft reports that its radiologists review, correct, and sign in the client's format. It provides flexible coverage for volume spikes, nights, and unfilled positions, and handles delivery to ordering providers, critical-finding notifications, and follow-up tracking.
2 investors
Rainfall Health provides a compliance and reimbursement-modeling platform built for the CMS TEAM Model, helping hospital CEOs and CFOs quantify and capture TEAM incentives across surgical episodes and the mandatory 30-day post-discharge window. It also offers auditing support and executive advisory guidance for healthcare systems navigating Medicare reimbursement changes.
2 investors
Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles. The company targets patients with chronic conditions who currently require painful injections.
2 investors
RareCan provides cancer treatment and clinical trial access tailored to individual patients, with a focus on improving outcomes for people diagnosed with rare cancers.
2 investors
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
2 investors
















